Endoscopic adrenalectomy in large adrenal tumors

Background The purpose of this study was to evaluate the frequency of malignancy, oncologic outcome and perioperative morbidity between small (≤60 mm) and large (>60 mm) adrenal tumors treated by endoscopic adrenalectomy (EA). Methods EA was performed in 289 consecutive patients with a mean follo...

Full description

Saved in:
Bibliographic Details
Published in:Surgery 2012-07, Vol.152 (1), p.41-49
Main Authors: Asari, Reza, MD, Koperek, Oskar, MD, Niederle, Bruno, MD
Format: Article
Language:English
Subjects:
Adrenal Gland Neoplasms - mortality
Adrenal Gland Neoplasms - pathology
Adrenal Gland Neoplasms - surgery
Adrenalectomy - adverse effects
Adrenalectomy - methods
Adult
Biological and medical sciences
Cohort Studies
Disease-Free Survival
Endoscopy - adverse effects
Endoscopy - methods
Feasibility Studies
Female
Follow-Up Studies
General aspects
Humans
Incidence
Male
Medical sciences
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Organ Size
Pheochromocytoma - mortality
Pheochromocytoma - pathology
Pheochromocytoma - surgery
Retrospective Studies
Surgery
Survival Rate
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The purpose of this study was to evaluate the frequency of malignancy, oncologic outcome and perioperative morbidity between small (≤60 mm) and large (>60 mm) adrenal tumors treated by endoscopic adrenalectomy (EA). Methods EA was performed in 289 consecutive patients with a mean follow-up of 87.7 ± 45.1 months. Patients were divided in those with tumor size ≤60 mm (group 1; n = 252) and >60 mm (group 2; n  = 37). Data on patient's age, gender, hormone function, tumor side, operation time, postoperative complications, conversion to open approach, and rate of malignancy were analyzed. Furthermore, disease-free survival in malignant tumors was estimated and compared between both groups. Results Patient age ( P = .43), gender ( P = .09), tumor side ( P = .17), and operative time ( P = .33) showed no difference in both groups. Functioning tumors were observed in 85% of patients in group 1 compared with 46% in group 2 ( P = .0001). Seven (2.8%) patients in group 1 and 7 (18.9%) in group 2 had malignant tumors ( P = .0001). Neither rate of conversion ( P = .71) and postoperative complication ( P = .27) nor recurrence of malignancy ( P = .48) differed between both groups. Estimated disease-free survival after 5 years in malignant lesions was 87.5 ± 11.7% for group 1 and 62.5 ± 21.3% for group 2 ( P = .49). Conclusion EA is a safe and feasible procedure in the majority of large adrenal tumors. Tumor size does not affect the outcome of surgery. In case of malignancy, it does not increase the rate of local recurrence. In experienced hands, tumor size should not influence the decision of surgical access (endoscopic versus open).
ISSN:0039-6060
1532-7361
DOI:10.1016/j.surg.2012.02.003